Selection of drug therapy in patients after bipolar transurethral resection of the prostate depending on its original size

Introduction. This study was aimed at dynamic evaluation of lower urinary tract symptoms (LUTS) after endoscopic surgery for benign prostatic hyperplasia (BPH) depending on prostate volume. Materials and methods: between January 2017 and February 2018, 288 bipolar transurethral resections were performed for BPH in D.D. Pletnev City Clinical Hospital. Twenty seven patients were excluded from this study. Depending on baseline BPH volume patients (n = 261) were distributed among three groups: 1 - less than 40 cc (n = 93), 2 - between 40 and 80 cc (n = 102), 3 - over 80 cc (n = 66). Depending on therapy every group was separated into three subgroups comprising of 31 (group 1), 34 (group 2) and 22 (group 3) patients each: subgroup I was treated with antibacterial drug and non-steroid anti-inflammatory drug suppositoria for 7 days, subgroup II additionally received tamsulosin for 3 months, and group III received tamsulosin and 6 mg solifenacin for 3 months. The following parameters were monitored: visual analog score (VAS, 0100), IPSS, QoL, post-void residual volume (PVR), uroflowmetry, mean voiding volume (MVV)...